Manhattan Scientifics Announces Agreement to Spin-Off and IPO its Senior Scientific Unit

Nov 29, 2016, MHTX, OTC Disclosure & News Service Manhattan Scientifics (OTCQB:MHTX) announces that it is implementing a plan to have Senior Scientific, the company’s cancer diagnostic unit, pursue an IPO and listing on the Australian Stock Exchange (ASX) (see description at end of release). Senior Scientific changed its name to Imagion Biosystems Inc. and will create a new board of industry professionals to be led by CEO Bob Proulx. The parent company, Manhattan Scientifics, owns 100% of Senior
http://bit.ly/2gfUFEK